Financhill
Back

Versus Systems Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
7

VS
Versus Systems

Last Price:
1.28
Seasonality Move:
-3.17%
Sell
30

ITCI
Intra-Cellular Therapies

Last Price:
68.47
Seasonality Move:
3.75%
Sell
7
Versus Systems (VS) is a Sell

Is Versus Systems a Buy, Sell or Hold?

  • The current Versus Systems [VS] share price is $1.29. The Score for VS is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • VS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $68.47. The Score for ITCI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VS Stock Price Chart

What is Versus Systems's stock price today?

  • The Versus Systems share price today is $1.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VS is experiencing slight selling pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $68.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

VS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 39 Sell
Chaikin Money Flow: -6236 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.29 - 1.65) Sell
Bollinger Bands (100): (1.38 - 2.08) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.98 Buy
Relative Strength Index (14 RSI): 44.97 Sell
Chaikin Money Flow: -3295600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.21 - 72.63) Sell
Bollinger Bands (100): (66.02 - 72.62) Sell

VS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.4 Sell
20-day SMA: 1.5 Sell
50-day SMA: 1.43 Sell
200-day SMA: 2.37 Sell
8-day EMA: 1.4 Sell
20-day EMA: 1.46 Sell
50-day EMA: 1.53 Sell
200-day EMA: 6.73 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.26 Sell
20-day SMA: 70.29 Sell
50-day SMA: 69.45 Sell
200-day SMA: 64.46 Buy
8-day EMA: 71.35 Sell
20-day EMA: 70.57 Sell
50-day EMA: 69.52 Sell
200-day EMA: 65.79 Buy

Versus Systems Earnings Growth & VS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

Versus Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):